CHICAGO, IL — A retrospective study of >24 000 Medicare patients supports something that has previously been demonstrated in rarified clinical-trial populations: namely, that just who is likely to ...
Study Reinforces Clinical and Economic Validity of Expanded Indication for Medtronic CRT-D Devices MINNEAPOLIS and BOSTON – Medtronic, Inc. today announced findings from an economic analysis of the ...
DUBLIN and BOSTON, Medtronic plc today announced study results demonstrating that its quadripolar cardiac resynchronization therapy (CRT) system gives physicians more options to optimize CRT delivery, ...
Results Provide Evidence Supporting Potential Expansion of Indications for CRT in Symptomatic, Permanent Atrial Fibrillation Patient Population MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)-- Data ...
Dialysis provider DaVita HealthCare Partners ($DVA) has partnered with Medtronic ($MDT) for a pilot program to study cardiac arrhythmias in end-stage renal disease ...
The COMPANION trial, presented in a late-breaking session here by Drs Arthur M Feldman and Michael R Bristow, was halted prematurely in November 2002 when the trial's data and safety monitoring board ...
This prospective, multicenter validation study accrued patients with stage IB-IVA cervical cancer treated with CRT between 2017 and 2022. Participants underwent phlebotomy at baseline, end of CRT, 4-6 ...
MINNEAPOLIS & BOSTON--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced findings from an economic analysis of the landmark RAFT (Resynchronization / Defibrillation in Ambulatory Heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback